The first patient, who was not tested for MiT-RCC, showed an FH mutation in the context of a hereditary leiomyomatosis and RCC cancer syndrome (Table 2) [41]. This evidence concerns the gene FH and hereditary leiomyomatosis and renal cell cancer.